Search research articles
Contact Us
Filters
Showing results (31-40 of 49) with videos related to
Page
of 5
Sort By:
Elife
|
December 24, 2021
Hyaluronic acid fuels pancreatic cancer cell growth
Peter K Kim, Christopher J Halbrook, Samuel A Kerk, et al.
Elife
|
February 2, 2023
Arginase 1 is a key driver of immune suppression in pancreatic cancer
Rosa E Menjivar, Zeribe C Nwosu, Wenting Du, et al.
JCI Insight
|
January 26, 2018
Mutant p53R270H drives altered metabolism and increased invasion in pancreatic ductal adenocarcinoma
Heather K Schofield, Jörg Zeller, Carlos Espinoza, et al.
Cell Metabolism
|
March 5, 2019
Macrophage-Released Pyrimidines Inhibit Gemcitabine Therapy in Pancreatic Cancer
Christopher J Halbrook, Corbin Pontious, Ilya Kovalenko, et al.
Nature Metabolism
|
April 1, 2026
NADPH-producing enzymes restrict the formation of pancreatic precancerous lesions
Megan D Radyk, Barbara S Nelson, Mariana Tannus Ruckert, et al.
Biorxiv : the Preprint Server for Biology
|
September 26, 2025
Mevalonate Biosynthesis is a Metabolic Vulnerability of Gemcitabine-resistant Pancreatic Cancer
Alica K Beutel, Sabrina Calderon, Ethan Nghiem, et al.
Cancer Discovery
|
January 9, 2020
Regulatory T-cell Depletion Alters the Tumor Microenvironment and Accelerates Pancreatic Carcinogenesis
Yaqing Zhang, Jenny Lazarus, Nina G Steele, et al.
Cancer & Metabolism
|
January 8, 2020
Tissue of origin dictates GOT1 dependence and confers synthetic lethality to radiotherapy
Barbara S Nelson, Lin Lin, Daniel M Kremer, et al.
Cancer Cell
|
September 15, 2012
EGF receptor is required for KRAS-induced pancreatic tumorigenesis
Christine M Ardito, Barbara M Grüner, Kenneth K Takeuchi, et al.
Nature Communications
|
August 1, 2020
Purine metabolism regulates DNA repair and therapy resistance in glioblastoma
Weihua Zhou, Yangyang Yao, Andrew J Scott, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 49) with videos related to
Sort By:
Page
of 5
Elife
|
December 24, 2021
Hyaluronic acid fuels pancreatic cancer cell growth
Peter K Kim, Christopher J Halbrook, Samuel A Kerk, et al.
Elife
|
February 2, 2023
Arginase 1 is a key driver of immune suppression in pancreatic cancer
Rosa E Menjivar, Zeribe C Nwosu, Wenting Du, et al.
JCI Insight
|
January 26, 2018
Mutant p53R270H drives altered metabolism and increased invasion in pancreatic ductal adenocarcinoma
Heather K Schofield, Jörg Zeller, Carlos Espinoza, et al.
Cell Metabolism
|
March 5, 2019
Macrophage-Released Pyrimidines Inhibit Gemcitabine Therapy in Pancreatic Cancer
Christopher J Halbrook, Corbin Pontious, Ilya Kovalenko, et al.
Nature Metabolism
|
April 1, 2026
NADPH-producing enzymes restrict the formation of pancreatic precancerous lesions
Megan D Radyk, Barbara S Nelson, Mariana Tannus Ruckert, et al.
Biorxiv : the Preprint Server for Biology
|
September 26, 2025
Mevalonate Biosynthesis is a Metabolic Vulnerability of Gemcitabine-resistant Pancreatic Cancer
Alica K Beutel, Sabrina Calderon, Ethan Nghiem, et al.
Cancer Discovery
|
January 9, 2020
Regulatory T-cell Depletion Alters the Tumor Microenvironment and Accelerates Pancreatic Carcinogenesis
Yaqing Zhang, Jenny Lazarus, Nina G Steele, et al.
Cancer & Metabolism
|
January 8, 2020
Tissue of origin dictates GOT1 dependence and confers synthetic lethality to radiotherapy
Barbara S Nelson, Lin Lin, Daniel M Kremer, et al.
Cancer Cell
|
September 15, 2012
EGF receptor is required for KRAS-induced pancreatic tumorigenesis
Christine M Ardito, Barbara M Grüner, Kenneth K Takeuchi, et al.
Nature Communications
|
August 1, 2020
Purine metabolism regulates DNA repair and therapy resistance in glioblastoma
Weihua Zhou, Yangyang Yao, Andrew J Scott, et al.
Page
of 5